Landscape Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.17M Buy
97,691
+54,047
+124% +$2.93M 0.27% 91
2026
Q1
$2.74M Buy
+43,644
New +$3.49M 0.17% 181
2023
Q4
Sell
-9,400
Closed -$496K 836
2023
Q3
$496K Sell
9,400
-6,946
-42% -$364K 0.07% 229
2023
Q2
$884K Buy
+16,346
New +$854K 0.12% 138
2019
Q4
Sell
-36,432
Closed -$1.48M 639
2019
Q3
$1.48M Sell
36,432
-37,387
-51% -$1.58M 0.11% 204
2019
Q2
$3.17M Buy
+73,819
New +$2.84M 0.25% 105
2018
Q1
Sell
-47,225
Closed -$1.17M 488
2017
Q4
$1.17M Buy
+47,225
New +$1.3M 0.1% 198

Other funds holding BSX

Landscape Capital Management's BSX Position: Q2 2026 in Review

Landscape Capital Management increased its Boston Scientific (BSX) stake by 124% in Q2 2026, buying an estimated $2.93M and bringing the position to 97,691 shares worth $4.17M. The position accounts for 0.27% of the portfolio, ranked #91.

Landscape Capital Management first reported a position in BSX in Q4 2017 and has held it in 7 quarters since. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Landscape Capital Management held 97,691 shares of Boston Scientific worth $4.17M as of Q2 2026.
  • Landscape Capital Management bought 54,047 Boston Scientific shares in Q2 2026, an estimated $2.93M.
  • Boston Scientific made up 0.27% of Landscape Capital Management's portfolio in Q2 2026, its #91 holding.
  • Landscape Capital Management first reported a position in Boston Scientific in Q4 2017 and has held it in 7 quarters since.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Landscape Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.